|Description||Mulberroside A, extracted from the root bark of white mulberry, could reduce P-gp expression and function being along with the activation of PKC and NF-κB. It has potential effect in the treatment of prevention of high uric acid and gout disease.|
|Solubility||DMSO: 40 mg/mL|
|Application||Mulberroside A, extracted from the root bark of white mulberry, could reduce P-gp expression and function being along with the activation of PKC and NF-κB.|
|Quality Standard||Enterprise Standard|
|Shelf Life||As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly|
13-Oxyingenol Dodecanoate is a derivative of Ingenol acts as a diterpene compound with antinematodal activity.
Napropamid is a selective systemic amide herbicide which is used against a number of annual grasses and broad-leaved weeds for inhibiting root development and g...
Sitamaquine tosylate is a dose-dependent and orally bioactive inhibitor of complex II (succinate dehydrogenase or SDH) of the respiratory chain in digitonin-per...
Ascorbyl palmitate is an ester formed from ascorbic acid and palmitic acid creating a fat-soluble form of vitamin C.
LY 135305 is a bio-active molecular under the development of Eli Lilly. It can inhibit spontaneous lung metastasis in a dose-dependent manner.
LAP is a cytocompatible, water soluble, Type I photoinitiator. It is used in the polymerization of hydrogels or other polymeric materials, specifically in the p...
GSK317354A is a G-Protein-Coupled Receptor Kinase 2 （GRK2） inhibitor，but no detailed information has been published yet.
Mifamurtide is a liposomal formulation containing a muramyl dipeptide (MDP) analogue with potential immunomodulatory and antineoplastic activities. It is a deri...